APOLLO Personalized RehAbilitation PrOgram In ALLOgeneic Bone Marrow Transplantation
About the role
Actively Recruiting
Age: 18Years - 70Years
All Genders
ID05579678
APOLLO Personalized rehAbilitation PrOgram in aLLOgeneic Bone Marrow Transplantation
Led by University of Alberta
Updated on 2026-05-11
45
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
Brief Title
Who Can Participate
AI-Screening
Your Study Journey
Trial Site Locations
Research Team
How is the study designed?
Frequently Asked Questions
Research Publications
AI-Summary
What This Trial Is About
People undergoing allogeneic bone marrow transplant for blood cancers receive the highest possible doses of chemotherapy that humans can survive, which leads to severe side effects both during the procedure and for many years afterwards. These side effects include lasting damage to organs and muscles causing physical weakness, and psychological effects severe enough to be called post traumatic stress disorder. Many patients face these difficulties largely on their own, especially those living far from treatment centers. This study explores the experiences of patients undergoing allogeneic bone marrow transplant while they have access to a supportive care program delivered through a computer app and supplemented by telephone support from nursing, exercise, and nutrition experts. The program aims to provide personalized rehabilitation through nursing, nutritional guidance, and physical activity support using a handheld app. Participants will be observed over one year to assess how acceptable and helpful this multimodal supportive care is. Researchers will gather detailed experiences and feedback to learn the most beneficial types and timing of support. The study involves monitoring participant experiences remotely via the app and telephone, focusing on physical and psychological well-being during and after the transplant process.
CONDITIONS
Brief Title
APOLLO: Personalized rehAbilitation PrOgram in aLLOgeneic Bone Marrow Transplantation
Who Can Participate
Age: 18Years - 70Years
All Genders
Eligibility Criteria
You may qualify if you...
Eligible for allogeneic transplantation
You will not qualify if you...
None
Research Team
E
Edith Pituskin, PhD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
On this page
AI-Summary
Brief Title
Who Can Participate
AI-Screening
Your Study Journey
Trial Site Locations
Research Team
How is the study designed?
Frequently Asked Questions
Research Publications
Sponsors
U
University of Alberta
Lead Sponsor
About DecenTrialz
DecenTrialz is the trusted digital partner for the clinical research ecosystem, dedicated to accelerating medical innovation by fundamentally democratizing access to clinical trials. Our unified platform is engineered to dismantle the systemic geographical, socioeconomic, and informational barriers that have long hindered participation, seamlessly connecting sponsors, CROs, and sites with a more diverse and engaged population of participants. Grounded in an unwavering commitment to trust, ethical principles, and regulatory compliance, we empower researchers with the intelligent tools needed for efficient recruitment while providing patients with a clear, secure, and accessible pathway to participation. Ultimately, our work forges a more inclusive and effective research landscape, speeding the delivery of life-changing therapies to humanity.
Vision:
We envision a world where clinical research is a shared global effort, not limited by geography, income, or background. In this future, every community has a seat at the table of discovery, and trials reflect the true diversity of humanity. By broadening access and accelerating participation, we aim to transform how quickly innovation turns into care, creating a healthier future that belongs to everyone.
Goals:
Our Goal is to democratize clinical research by opening participation to people everywhere and ensuring diverse voices are represented in discovery. We work to remove barriers that slow progress, so research can move faster and bring new treatments to patients who need them. By making trials more inclusive and representative, we aim to strengthen trust in science and ensure that Medical breakthroughs serve humanity as a whole.
Similar Jobs
APOLLO Personalized RehAbilitation PrOgram In ALLOgeneic Bone Marrow Transplantation
About the role
Actively Recruiting
Age: 18Years - 70Years
All Genders
ID05579678
APOLLO Personalized rehAbilitation PrOgram in aLLOgeneic Bone Marrow Transplantation
Led by University of Alberta
Updated on 2026-05-11
45
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
Brief Title
Who Can Participate
AI-Screening
Your Study Journey
Trial Site Locations
Research Team
How is the study designed?
Frequently Asked Questions
Research Publications
AI-Summary
What This Trial Is About
People undergoing allogeneic bone marrow transplant for blood cancers receive the highest possible doses of chemotherapy that humans can survive, which leads to severe side effects both during the procedure and for many years afterwards. These side effects include lasting damage to organs and muscles causing physical weakness, and psychological effects severe enough to be called post traumatic stress disorder. Many patients face these difficulties largely on their own, especially those living far from treatment centers. This study explores the experiences of patients undergoing allogeneic bone marrow transplant while they have access to a supportive care program delivered through a computer app and supplemented by telephone support from nursing, exercise, and nutrition experts. The program aims to provide personalized rehabilitation through nursing, nutritional guidance, and physical activity support using a handheld app. Participants will be observed over one year to assess how acceptable and helpful this multimodal supportive care is. Researchers will gather detailed experiences and feedback to learn the most beneficial types and timing of support. The study involves monitoring participant experiences remotely via the app and telephone, focusing on physical and psychological well-being during and after the transplant process.
CONDITIONS
Brief Title
APOLLO: Personalized rehAbilitation PrOgram in aLLOgeneic Bone Marrow Transplantation
Who Can Participate
Age: 18Years - 70Years
All Genders
Eligibility Criteria
You may qualify if you...
Eligible for allogeneic transplantation
You will not qualify if you...
None
Research Team
E
Edith Pituskin, PhD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
On this page
AI-Summary
Brief Title
Who Can Participate
AI-Screening
Your Study Journey
Trial Site Locations
Research Team
How is the study designed?
Frequently Asked Questions
Research Publications
Sponsors
U
University of Alberta
Lead Sponsor
About DecenTrialz
DecenTrialz is the trusted digital partner for the clinical research ecosystem, dedicated to accelerating medical innovation by fundamentally democratizing access to clinical trials. Our unified platform is engineered to dismantle the systemic geographical, socioeconomic, and informational barriers that have long hindered participation, seamlessly connecting sponsors, CROs, and sites with a more diverse and engaged population of participants. Grounded in an unwavering commitment to trust, ethical principles, and regulatory compliance, we empower researchers with the intelligent tools needed for efficient recruitment while providing patients with a clear, secure, and accessible pathway to participation. Ultimately, our work forges a more inclusive and effective research landscape, speeding the delivery of life-changing therapies to humanity.
Vision:
We envision a world where clinical research is a shared global effort, not limited by geography, income, or background. In this future, every community has a seat at the table of discovery, and trials reflect the true diversity of humanity. By broadening access and accelerating participation, we aim to transform how quickly innovation turns into care, creating a healthier future that belongs to everyone.
Goals:
Our Goal is to democratize clinical research by opening participation to people everywhere and ensuring diverse voices are represented in discovery. We work to remove barriers that slow progress, so research can move faster and bring new treatments to patients who need them. By making trials more inclusive and representative, we aim to strengthen trust in science and ensure that Medical breakthroughs serve humanity as a whole.